Welcome to LookChem.com Sign In|Join Free

CAS

  • or

836-21-5

Post Buying Request

836-21-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

836-21-5 Usage

General Description

1-Benzyl-3,5-dimethylpiperidin-4-one, also known as BDMP, is a chemical compound commonly used in the synthesis of pharmaceuticals and agrochemicals. It is a piperidinone derivative with a benzyl group and two methyl groups attached to the piperidine ring. BDMP is known for its role as an intermediate in the production of various drugs and can also be used in the development of organic synthesis. The compound has a wide range of applications due to its unique molecular structure, and it is often utilized in the pharmaceutical and agricultural industries for its beneficial properties.

Check Digit Verification of cas no

The CAS Registry Mumber 836-21-5 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 8,3 and 6 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 836-21:
(5*8)+(4*3)+(3*6)+(2*2)+(1*1)=75
75 % 10 = 5
So 836-21-5 is a valid CAS Registry Number.

836-21-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-benzyl-3,5-dimethylpiperidin-4-one

1.2 Other means of identification

Product number -
Other names 1-benzyl-3,5-dimethyl-4-piperidone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:836-21-5 SDS

836-21-5Relevant articles and documents

CHEMOKINE RECEPTOR ANTAGONISTS AND METHODS OF USE THEREOF

-

Paragraph 1165; 1166; 1167, (2016/02/21)

Disclosed are novel compounds and a method of treating a disease associated with aberrant leukocyte recruitment and/or activation. The method comprises administering to a subject in need an effective amount of a compound represented by: or physiologically acceptable salt thereof.

CCR8 INHIBITORS

-

Page 26; 29, (2008/06/13)

Disclosed is an inhibitor of CCR8 that is represented by Structural Formula (I). Also disclosed are pharmaceutical compositions comprising a pharmaceutically acceptable carrier or diluent and a CCR8 inhibitor represented by Structural Formula (I). Also disclosed is a method of treating inflammatory disorders in a subject by administering a CCR8 inhibitor to the subject.

Chemokine receptor anagonists and methods of use therefor

-

, (2008/06/13)

Disclosed are novel compounds and a method of treating a disease associated with aberrant leukocyte recruitment and/or activation. The method comprises administering to a subject in need an effective amount of a compound represented by: or physiologically acceptable salt thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 836-21-5